A
Arjen L. Sutterland
Researcher at University of Amsterdam
Publications - 36
Citations - 1039
Arjen L. Sutterland is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Schizophrenia & Population. The author has an hindex of 10, co-authored 34 publications receiving 750 citations. Previous affiliations of Arjen L. Sutterland include Erasmus University Rotterdam.
Papers
More filters
Journal ArticleDOI
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis
Arjen L. Sutterland,Guillaume Fond,Anne Kuin,Maarten W. J. Koeter,René Lutter,T. van Gool,Robert H. Yolken,Andrei Szöke,Marion Leboyer,L. de Haan +9 more
TL;DR: A meta‐analysis on studies reporting prevalence of Toxoplasma gondii infection in any psychiatric disorder compared with healthy controls to analyze factors possibly moderating heterogeneity.
Journal ArticleDOI
Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years.
Jentien M Vermeulen,Geeske van Rooijen,Marita van de Kerkhof,Arjen L. Sutterland,Christoph U. Correll,Christoph U. Correll,Lieuwe de Haan +6 more
TL;DR: Continuous clozapine treatment in schizophrenia patients was associated with a significantly lower long-term all-cause mortality rate compared to other antipsychotic use, giving reason to re-evaluate the hesitancy to prescribe clozAPine in regular care settings.
Journal ArticleDOI
Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis.
TL;DR: Meta-regression analysis showed that the effects of baclofen were stronger when daily alcohol consumption before inclusion was higher, and Baclofen seems to be effective in the treatment of AD, especially among heavy drinkers.
Journal ArticleDOI
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Nuray Çakici,Arjen L. Sutterland,Brenda W.J.H. Penninx,Virgil A. S. H. Dalm,Lieuwe de Haan,Nico J.M. van Beveren +5 more
TL;DR: The findings support efforts for further research into transdiagnostic preventive strategies and augmentation therapy for those with immune or metabolic dysfunctions in schizophrenia and major depressive disorder.
Journal ArticleDOI
Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study
Jojanneke S. Kroon,Tamar Wohlfarth,Jeanne P. Dieleman,Arjen L. Sutterland,Jitschak G. Storosum,Damiaan Denys,Damiaan Denys,Lieuwe de Haan,Mirjam C J M Sturkenboom +8 more
TL;DR: To estimate the incidence rates (IRs) of bipolar I and bipolar II disorders in the general population according to sociodemographic population characteristics, a large number of patients with these disorders are diagnosed with bipolar I or II disorders.